NCT02858778
Unknown
Not Applicable
A Randomized Allocation of Palliative Care Consultation in the Emergency Department Compared to Usual Practice
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Multiple Organ Failure
- Sponsor
- Wayne State University
- Enrollment
- 120
- Locations
- 2
- Primary Endpoint
- The difference in the percentage of patients with a completed advance directive (AD) in Ig vs.Cg
- Last Updated
- 9 years ago
Overview
Brief Summary
A prospective randomized controlled trial studying the ordering of palliative care consultations in the emergency department (Ig) versus later palliative care consultations in the hospital--ICU or hospital ward(Cg). Patients will be randomly allocated to Ig or Cg with a 1:1 ratio.
Investigators
Robert Zalenski
Principle Investigator
Wayne State University
Eligibility Criteria
Inclusion Criteria
- •Greater than or equal to 65 years old
- •Treated in a resuscitation room for unstable vital signs or respiratory compromise
- •One or more of the following:
- •Advanced or metastatic solid organ cancer
- •End stage organ failure of the heart, lung/COPD, kidney on dialysis, hepatic encephalopathy
- •Suspected sepsis
- •Advanced dementia, end-state multiple sclerosis or Parkinson's disease
- •Status post cardiac arrest with coma (Glascow coma score \<7)
- •Patient is from a skilled nursing facility
Exclusion Criteria
- •Lack decision capacity and have no relative available during ED stay to consent to the study (legally authorized representative-LAR)
- •Enrolled in hospice care prior to randomization
- •A copy of a completed advance directive which names a designated proxy provided physically to the medical team prior to randomization
- •Wearing a DNR bracelet
- •Have been previously enrolled in this study
Outcomes
Primary Outcomes
The difference in the percentage of patients with a completed advance directive (AD) in Ig vs.Cg
Time Frame: 1 year
Secondary Outcomes
- The proportion of billed CMS ACP-CPT codes in Ig vs. Cg(30 days from enrolled patients' hospital discharge)
- Matches of care received to patient-specific preferences in Ig vs. Cg(1 year)
- Patient/family satisfaction with care in Ig vs. Cg(Baseline)
- Amount of hospice referrals in Ig vs. Cg(1 year)
- Time to consultation in Ig vs. Cg groups(1 year)
- Hospital total direct costs for the index visit in Ig vs. Cg(1 year)
- Hospital and ICU length of stay in Ig vs. Cg(1 year)
- Average days in hospice in Ig vs. Cg(1 year)
- Hospital margin contribution for the index visit in Ig vs. Cg(1 year)
Study Sites (2)
Loading locations...
Similar Trials
Completed
Not Applicable
Stepped Palliative Care Versus Early Integrated Palliative Care in Patients With Advanced Lung CancerLung CancerNCT03337399Massachusetts General Hospital510
Completed
Not Applicable
Randomized Evaluation of Default Access to Palliative ServicesCOPDESRDDementiaNCT02505035University of Pennsylvania34,239
Completed
Not Applicable
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung CancersHealthy SubjectLocalized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterPsychosocial Effects of Cancer and Its TreatmentRecurrent Bladder CancerRecurrent Cervical CancerRecurrent Colon CancerRecurrent Gastric CancerRecurrent Ovarian Epithelial CancerRecurrent Ovarian Germ Cell TumorRecurrent Pancreatic CancerRecurrent Rectal CancerRecurrent Renal Cell CancerRecurrent Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Urethral CancerRecurrent Uterine SarcomaRegional Transitional Cell Cancer of the Renal Pelvis and UreterStage II Bladder CancerStage II Renal Cell CancerStage II Urethral CancerStage IIA Cervical CancerStage IIA Colon CancerStage IIA Gastric CancerStage IIA Ovarian Epithelial CancerStage IIA Ovarian Germ Cell TumorStage IIA Pancreatic CancerStage IIA Rectal CancerStage IIA Uterine SarcomaStage IIB Cervical CancerStage IIB Colon CancerStage IIB Gastric CancerStage IIB Ovarian Epithelial CancerStage IIB Ovarian Germ Cell TumorStage IIB Pancreatic CancerStage IIB Rectal CancerStage IIB Uterine SarcomaStage IIC Colon CancerStage IIC Ovarian Epithelial CancerStage IIC Ovarian Germ Cell TumorStage IIC Rectal CancerStage III Bladder CancerStage III Pancreatic CancerStage III Renal Cell CancerStage III Urethral CancerStage IIIA Cervical CancerStage IIIA Colon CancerStage IIIA Gastric CancerStage IIIA Ovarian Epithelial CancerStage IIIA Ovarian Germ Cell TumorStage IIIA Rectal CancerStage IIIA Uterine SarcomaStage IIIB Cervical CancerStage IIIB Colon CancerStage IIIB Gastric CancerStage IIIB Ovarian Epithelial CancerStage IIIB Ovarian Germ Cell TumorStage IIIB Rectal CancerStage IIIB Uterine SarcomaStage IIIC Colon CancerStage IIIC Gastric CancerStage IIIC Ovarian Epithelial CancerStage IIIC Ovarian Germ Cell TumorStage IIIC Rectal CancerStage IIIC Uterine SarcomaStage IV Bladder CancerStage IV Gastric CancerStage IV Ovarian Epithelial CancerStage IV Ovarian Germ Cell TumorStage IV Pancreatic CancerStage IV Renal Cell CancerStage IV Urethral CancerStage IVA Cervical CancerStage IVA Colon CancerStage IVA Rectal CancerStage IVA Uterine SarcomaStage IVB Cervical CancerStage IVB Colon CancerStage IVB Rectal CancerStage IVB Uterine SarcomaUreter CancerStage IIA Lung CarcinomaStage IIB Lung CarcinomaStage IIIA Lung CarcinomaStage IIIB Lung CarcinomaNCT01846520City of Hope Medical Center200
Withdrawn
Not Applicable
Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic NeoplasmPancreatic NeoplasmNCT06545344Fred Hutchinson Cancer Center40
Terminated
Not Applicable
LOTCOL Study: Local Treatment of Colo-rectal Liver MetMetastatic Colo-rectal CancerNCT01867918Oslo University Hospital3